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Summary.-Local injection (i.e. injection at the site of tumour inoculation) of strains
of C. Parvum which have a significant anti-tumour effect when given systemically
(i.e. intravenously or, in the case of subcutaneous tumour transplant, intraperi-
toneally) strongly inhibits the growth of isogeneic transplants of a fibrosarcoma
in intact CBA mice but has little or no effect on subcutaneous transplants of the
same tumour in T-cell deprived mice. The anti-tumour effect of local injection
of C. parvum, unlike that of systemic injection in this particular tumour system,
thus appears to be T-cell dependent.
PRELIMINARY observations of our own
with a mouse fibrosarcoma, and experi-
ments with other mouse tumours recently
reported by Likhite and Halpern (1974)
and Scott (1974), have shown that intra-
tumour injection of C. parvum may
strongly inhibit tumour growth and under
some conditions cause complete regression.
The present experiments were designed
to investigate this phenomenon further,
using both subcutaneous and intraperito-
neal tumour transplants. To exclude
purely mechanical effects we have com-
pared the degree of tumour inhibition
resulting from local injection of3anaerobic
coryneforms which differ markedly in their
effect on tumour growth when given
systemically, and of an aerobic organism,
C. diphtheriae.
We have used as tumour hosts both
intact and T-cell deprived mice, because in
our own experience (Wooodruff and Dun-
bar, 1972; Woodruff, Dunbar and Ghaffar,
1973), the anti-tumour effect of systemic
injections of active strains of C. parvum
in respect of cholanthrene induced
sarcomata is maintained in T-cell deficient
mice, whereas Scott (1974) has reported
that the growth of a mastocytoma, is
inhibited by intratumour injection of
C. parvum in intact mice but not in T-cell
deprived mice.
MATERIALS AND METHODS
Mice.-The recipient mice were either
intact adult CBA females (20-22 g) or T-cell
deprived CBA females prepared as described
previously (Woodruff et al., 1973).
Tumour. The tumour was originally
induced in a female CBA mouse with methyl-
cholanthrene. Itwasstoredinliquidnitrogen
after 1]5 transplant generations and was trans-
planted once more before being used in the
experiments. The properties of this tumour
have been summarized in a recent review
(Woodruff, 1975). It was transplanted
subcutaneously (right foreleg) or intraperi-
toneally, or by both these routes, in the form
of a cell suspension prepared with pronase in
a dosage (unless otherwise stated) of 104 cells.
The mice were inspected and weighed
every 2 days. If a subcutaneous tumour
was present, its width in 2 directions at right-
angles was measured with a caliper and the
mean was recorded. Where appropriate, the
diameters of subcutaneous tumours were
summed, as described previously (Woodruff
et al., 1973), up to the day when some of the
tumours in control mice were 18-20 mm in
diameter, and the group mean sums were
compared byStudent's t-test. Inmanycases,
however, the differences between groups were
sufficiently clearcut to make thisunnecessary.EFFECT OF LOCAL INJECTION OF CORYNEBACTERIUIM PARVUM
Organisms-i8.The 3 strains of anaerobic
corynebacteria are designated CN6134,
10387(1) and 10387(2). CN6134 was kindly
provided by the Wellcome Foundation. The
other 2 strains were grown by Dr W. McBride,
ofthe Department ofBacteriology, University
of Edinburgh, from a culture (NTC 10387)
obtained originally from the National Col-
lection of Type Cultures, Colindale, London.
10387(1) has negligible effect when given by
intravenous (i.v.) or intraperitoneal (i.p.)
injection 3 days after subcutaneous tumcur
inoculation (Woodruff and Dunbar, 1972);
10387(2) inhibits tumour growth to some
extent when given i.v. or i.p. but is much less
effective than CN6134 (McBride et al., 1975).
It is of interest that 3 other distinguishable
strains derived from NTC 10387 were studied
by O'Neill, Henderson and White (1973), so
it seems likely that the original culture from
Colindale contained a mixture of organisms.
AformolkilledsuspensionofC. diphtheriae
containing 7 mg dry weight organism per ml
(i.e. the same as the suspension of CN6134)
was kindly prepared for us by the Wellcome
Fouiidation. This material, given i.p. or
i.v. in a dosage of 1-4 mgdryweightorganisms,
has no demonstable anti-tumour effect.
All the organisms were injected in the
form of a formalin killed suspension by one
of the following routes: (1) intravenously, to
a tail vein (i.v.); (2) intraperitoneally (i.p.);
(3) subcutaneously to a limb which had not
been used for tumour inoculation (s.c.); (4)
subcutaneously to a limb which had been
used for tumour inoculation at an adjacent
site (s.c. adj.): (5) at the site of subcutaneous
tumour inoculation or into a palpable subcu-
taneous tumour (i.t.).
The dose, expressed as the dry weight of
organisms, was either 1-4 mg or 0 7 mg. The
volume of suspension injected was usually
0-1 ml; occasionally 0-05 ml was used for
s.c., s.c. adj. and i.t. injection and 0-2 ml
for i.p. injection.
RESULTS
The effect on tumour growth of 3
different organisms injected by various
routes after s.c. tumour inoculation is
shown in Fig. 1-3, each of which relates
to a separate experiment with 6 mice in
each treatment group. It will beseenthat
C. diphtheriae and C. parvum strain 10387
(1), which are iineffective when given
systemically (i.v. or i.p.), were also ineffec-
tive (Fig. 1) when injected at the site of
tumour inoculation (i.t.). C. parvum strain
10387(2), which has a slight anti-tumour
effect when given systemically, had a
somewhat greater effect when injected
i.t. (Fig. 3). C. parvum strain CN6134,
which is considerably more effective than
10387(2) when given systemically, had
an even more marked effect when injected
i.t. (Figs. 1,2,3). In one experiment i.t.
injection of this strain (CN6134) 3 days
after subcutaneous inoculation of 104
viable tumour cells completely suppressed
the development of tumours (Fig. 2) and
it was found subsequently that the mice
had become resistant to challenge with
105 viable cells. Injection at a site
adjacent to tumour inoculation also pro-
vided some degree of inhibition, as judged
by comparison with tumour growth in
untreated control mice (t 1-91, n 10,
P<0 05) though it was less effective than
i.v. or i.p. injection, whereas subcutaneous
injection at a site remote from tumour
inoclation was ineffective. In another
experiment (Fig. 3), injection of strain
CN6134 into palpable tumours about
4 mm in diameter also appeared to cause
significant inhibition, as judged by the
difference in mean tumour diameter in
treated and control animals 2 weeks later
(t=-239, n-10, P<0 05).
The effect ofC. parvum (strainCN6134)
on the survival of mice after intraperito-
neal inoculation of 104 viable tumour
cells is illustrated in Figs. 4 and 5. After
an i.p. injection of C. parvrum on Day 3
(i.e. 3 days after tumour inoculation) all
the mice in one experiment (Fig. 4)
remained tumour-free and became resis-
tant to subsequent s.c. challenge with 105
viable tumour cells. In another experi-
ment (Fig. 5) 3 of 6 mice which received
an i.p. injection of C. parvum on Day 3,
and 2 of 6 which received an i.p. injection
on Day 7, remained tumour-free, and in
5 of the 7 animals which were not cured
death was due to a large subcutaneous
35M. F. A. WOODRUFF AND N. DUNBAR
18
16
14
E 12
E 10
E
C
) 84
-6-
a)
a)4
5 10 15
Time (days)
20 25
FiG. 1. Effect on tumour growth of a single injection of a formol killed bacterial suspension giveil
3 days after subcutaneous inoculation of 105 viable tumour cells to R. leg. The dose was 1-4 mg
dry weight organisms suspended in 1-4 ml when given i.p., otherwise 0-2 mg in 005 ml. * 0
Untreated controls, A A C. parvum 10387(1) to site of tumour inoculation, O D C. parvurn
CN6134 by subcutaneous injection to leg, **] C. parvumn CN6134 by intraperitoneal injection.
C. parvum CN6134 to site of tumour inoculation. Tumour growth after injection
ofC. diphtheriae to site oftumourinoculation was indistinguishable from growthinuntreated controls
and has not been plotted.
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FIG. 2.-Effect on tumour growth ofa single injection of C. parvurn CN6134 (0 7 mg dry weight organ-
isms in 0-1 ml) given by various routes 3 days after subecutaneous inoculation of 104 viable tumour
cells to R. leg. * * Untreated controls, O []C. parvumsubcutaneously to I,. leg, x /
C. parvum subcutaneously near site of tumour inoculation, 0 O C. parvum by intravenous
injection, U -. C. parvum by intraperitoneal injection, w w C. parvum to site of tumour
inoculation.
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FIa. 3.--Effect on tumour growth of a single injection of C. par,vum (0.7 mg dry weight organisms in
0-1 ml) to the site of tumour inoculation (or into a palpable tumour) 3 or 9 days after subcutaneous
inoculation of 104 viable tumour cells. 0-* Untreated controls, ni] D C. parvum 10387(2)
Day 9, * U C. parvum CN6134 Day 9, A A C. parvurn 10387(2) Day 3, A * C.parvum
CN6134 Day 3.
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FIG. 4. --Survival of mice after intraperitoneal inoculation of 104 viable tumour cells followed 3 days
later by a single injection of C. parvum CN6134. Untreated controls, C. parvumr
by subcutaneous injection, - C. parvum by intravenous injection .. C. parvum by
intraperitoneal injection.
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FI(G,. 5. Survival of mice after intraperitoneal inoculation of 104 viable tumour cells on Day 0.
Treated mice received a single intraperitoneal injection of C. parvum CN6134 on Day +3, +7 or
+ 14.0 0 No treatment, A A C. parvum Day 14, A A C. parvum Day 7, n :j c.
parvumn Day 3.
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Fi(c. 6.-Growth of subcutaneous tumour following either subcutaneous inoculation (R. leg), or simul-
taneous subcutaneous (R. leg) and intraperitoneal inoculation, of 104 viable tumour cells on Day 0.
* 0* Subcutaneous tumour inoculation only, untreated controls; 0 O subcutaneous
+intraperitoneal tumour inoculation, (untreated controls); O O subcutaneous + intraperi-
toneal tumour inoculation, C. parvum (CN6134) by intraperitoneal injection on Day 3; * U
subcutaneous tumour inoculation only, C. parvum (CN6134) to site ofinoculation Day 3; A A
subcutaneous + intraperitoneal tumour inoculation, C. parvurn (CN6134) to site of subcutaneous
inoculation on Day 3.
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FIe. 7. Survival ofmice after inoculation of 1O4 viable tumour cells subcutaneously, intraperitoneally
or by both routes on Day 0. Treatment on Day + 3. *0- -0 subcutaneous + intraperi-
toneal tumour, no treatment; 0 -- * subcutaneous tumour only, no treatment;
O O intraperitoneal tumour only, no treatment; * * subcutaneous 4- intra-
peritoneal tumour, C. parvum CN6134 intraperitoneally; * - - subcutaneous + intra-
peritoneal tumour; C. parvurn CN6134 to site of tumour inocuilation; O O intraperitoneal
tumour only, C. parvum CN6134 intraperitoneally; 0- - -0 subcutaneous tumour only. C.
parvumn CN6134 to site of tumour inoculation.
tumour near the site of i.p. inoculation,
presumably caused by escape ofcells when
the needle was withdrawn, and no tumour
was found in the peritoneal cavity at
autopsy. Intraperitoneal injection of C.
parvum on Day 14 doubled the mean sur-
vival time (41.0 days compared with 21-0
in the untreated controls) but did not
cure any of the mice.
The results in mice inoculated with 104
viable tumour cells both s.c. and i.p. at
the same time are shown in Figs. 6 and 7.
Groups of animals injected at one site
only were included for comparison. In
the absence of treatment, growth at the
s.c. site was slower in mice which had also
been inoculated intraperitoneally than in
those inoculated only subcutaneously but
death occurred a little earlier (mean sur-
vival 18 days after s.c. and i.p. inoculation,
23*3 days after s.c. inoculation only). C.
parvum i.p. inhibited growth at the s.c.
site, though not to the same extent as
C. parvum i.t., and markedly prolonged
life (mean survival 40-2 days). Moreover,
death after i.p. C. parvurn was determined
purely by the s.c. tumour and none ofthese
had i.p. tumour at autopsy. C. parvum
i.t. inhibited growth at the s.c. site to at
least the same extent as it did in mice
with s.c. tumour only, and markedly
prolonged life (mean survival 41-5 days).
Figure 8 shows the results of an experi-
ment set up to compare the effect of i.t.
injection ofC. parvum 3 days after tumour
inoculation in intact and T-cell deprived
mice. As we have reported previously
(Woodruff and Dunbar, 1972; Woodruff
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Fic'l(. 8.--Effect of local injection of C. parcvuin (strain CN6134) 3 days after subcutaneous inoculation
of 104 viable tumouir cells in intact and T-cell deprived mice. * * Intact mice, no treatment;
O O T-cell (leprived mice, no treatment; * -- Intact mice, C. parvuin to site of tumour
inioctulation; C- O T-cell deprive(d mice, C. parvum to site of tumour inoculation.
et al., 1973) the tumour grows more slowly
in untreated T-cell deprived mice than in
untreated intact mice, and is inhibited by
i.p. injection of C. parvum to much the
same extent in both categories of mouse.
Injection ofC. parvum atthesiteoftumour
inoculation, however, appeared to be
ineffective in T-cell deprived mice.
D)ISCUSSION
Our results confirm and extend those
of Likhite and Halpern (1974), and Scott
(1974), and establish beyond doubt that
local injection of strains of C. parvum
which have a significant anti-tumour
effect when given systemically strongly
inhibits tumour growth in intact mice
whether the tumour (and hence the local
injection of C. parvum) is situated sub-
cutaneously or in the peritoneal cavity.
Moreover, animals in whichtumourgrowth
is completely suppressed following local
injection of C. parvum become strongly
resistant to a second inoculation oftumour
cells.
The effect cannot be attributed to
mechanical dispersion of tumour cells or
disruption of a growing tumour because
organisms which are morphologically
similar but fail to inhibit tumour growth
when given systemically arealsoineffective
when given locally.
It seemed at first that the most likely
explanation of the anti-tumour effect of
local injection of C. parvum was that it
promoted the accumulation of macro-
phages at the site of tumour inoculation.
The observation ofScott (1974), which our
own findings appear to confirm, that local
injection of C. parvum in T-cell deprived
mice is relatively ineffective whereas, as
previously reported (Woodruff et al.,
1973), systemic injection is just as effective
as in intact mice, would seem to imply
that this simple explanation cannot be the
whole story and raises again the question
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of whether the residual T-cell population
in deficient mice is expanded following
systemic injection of C. parvum and
contributes in some way to the anti-
tumour effect.
Further experiments are planned to
investigate this hypothesis, but as a first
step it is proposed to find out whether the
phenomenon is indeed a general one by
conducting similar experiments to those
described with other tumours and in
congenitally athymic mice.
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